Fundraising Fox1315 Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesCranbury, US
David Wood(Executive Officer, Director)in
BoardDerek Hennecke(Director)inMatthew Reber(Director)Thomas Weller(Director)William Mitchell(Director)Andrew Frazier(Director)
Primrose Bio develops high-efficiency production systems for innovative and complex biologics, using advanced protein expression and enzyme engineering technologies deployed across commercially proven platforms.
BiotechDeep TechMedical DevicesSan Diego, US
Helge Zieler(Director, Executive Officer)inDrew Burch(Chief Executive Officer)Diane Retallack, PhD(President & Chief Operating Officer)
BoardJ. Todd Mitchell(Director)Matthew Korenberg(Director)Matthew Reber(Director)
Co-investorsAgent Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.